Connect with us

Hi, what are you looking for?


PHL, India return to pre-pandemic levels by end-2022 uncertain

MOODY’S ANALYTICS said the recovery in the Philippines and India will lag the rest of the Asia-Pacific (APAC), with both countries struggling to restore their economies to pre-pandemic levels by the end of next year.

In a note issued Wednesday, “The APAC Economy: Looking Forward to 2021,” Moody’s Analytics Chief Asia-Pacific Economist Steven Cochrane said in the case of the Philippines, the coronavirus disease 2019 (COVID-19) outbreak remains uncontained, while the government’s stimulus spending is among the smallest in the region.

In the report, Moody’s Analytics downgraded its 2020 gross domestic product forecast for the Philippines to a contraction of 9.9% from the 8.2% contraction it projected in November.

It now expects the economy to grow 4.5% this year and 6.2% in 2022.

“Much of the region will have regained all of its lost output by the end of 2021, although India and the Philippines will struggle to reach this benchmark by the end of 2022,” it said.

On Wednesday, Bangko Sentral ng Pilipinas Governor Benjamin E. Diokno said at a forum that the Philippines is expected to recover the economic output lost last year by mid-2022.

Mr. Cochrane said the region is poised to bounce back stronger than the rest of the world as most countries in the region have contained their outbreaks, except for the Philippines and Indonesia. He added that the region’s manufacturing supply chains are focused on goods in demand during the recovery phase, like computers, mobile phones, technology equipment, pharmaceuticals and protective gear.

Accommodative monetary policy by central banks in the region will also help fast-track the rebound, coupled with large recovery packages.

He said the Philippines and India will lag their peers because the two governments were “least committed to fiscal stimulus, even though they were the two most hard-hit economies from COVID-19 and their subsequent lengthy and strict quarantine policies.”

The note also cited the region’s relatively fast action in procuring COVID-19 vaccines.

“An important exception is the Philippines, which has made little progress so far,” it added.

Citing data from the Duke Global Health Innovation Center, Moody’s Analytics noted that only the Philippines has not yet bought any COVID-19 vaccines out of the 21 economies tracked.

“Currently, however, there remains a risk that the smaller emerging markets in APAC will be among the last to have enough vaccine doses,” Mr. Cochrane said.

He said the region could also benefit from an expected foreign policy shift when President-elect Joseph R. Biden, Jr. takes office this month.

“Yet whether still struggling to gain lost output or expanding their economies to new heights, all countries within APAC will grow in the coming year. Risks to the outlook include the perniciousness of COVID-19, which could cause deeper economic shutdowns in Europe and North America that would staunch the global trade in goods that is so important to the APAC economy.” — Beatrice M. Laforga

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



There is growing concern that free, face-to-face advice which helps hundreds of thousands out of debt each year could be cut. New contracts from...


The Bank of England’s new chief economist has warned that UK inflation is likely to hit or surpass 5% by early next year. Huw...


By Luz Wendy T. Noble, Reporter  The Philippines expects to narrow its budget deficit, with the government having raised tax collections as of end-September amid a coronavirus...


The Philippine economy is expected to grow by 4.3% this year — slower than originally expected — due to recurring coronavirus infection surges in the region, according to the ASEAN+3 Macroeconomic...


By Luz Wendy T. Noble, Reporter The Philippine central bank sold P100 billion worth of 28-day bills on Friday, with rates slipping as it...


The Department of Health reported 5,823 coronavirus cases on Friday, bringing the total to 2.7 million.  The death toll rose to 41,520 after 283 more patients...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...


As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...


Pfizer Inc on Wednesday raised its 2021 sales forecast for its COVID-19 vaccine by 29% to $33.5 billion, and said it believes people will...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!